J. Blaser

2.0k total citations · 1 hit paper
51 papers, 1.6k citations indexed

About

J. Blaser is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, J. Blaser has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmacology, 17 papers in Molecular Medicine and 15 papers in Epidemiology. Recurrent topics in J. Blaser's work include Antibiotics Pharmacokinetics and Efficacy (28 papers), Antibiotic Resistance in Bacteria (17 papers) and Pneumonia and Respiratory Infections (8 papers). J. Blaser is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (28 papers), Antibiotic Resistance in Bacteria (17 papers) and Pneumonia and Respiratory Infections (8 papers). J. Blaser collaborates with scholars based in Switzerland, United States and United Kingdom. J. Blaser's co-authors include Stephen H. Zinner, R Lüthy, Christiane König, Hans‐Peter Simmen, Milos Opravil, Pietro Giovanoli, Andreas F. Widmer, W. Zimmerli, W Siegenthaler and M. P. Glauser and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

J. Blaser

50 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

1987 397 citations J. Blaser, Stephen H. Zinner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Blaser Switzerland	21	995	654	544	363	271	51	1.6k
Sigurður Guðmundsson Iceland	24	1.1k 1.1×	753 1.2×	819 1.5×	399 1.1×	305 1.1×	56	2.2k
Marie-Dominique Kitzis France	19	683 0.7×	799 1.2×	523 1.0×	411 1.1×	198 0.7×	48	1.5k
H. C. Neu United States	26	1.0k 1.0×	682 1.0×	552 1.0×	437 1.2×	240 0.9×	70	1.9k
Alison Meagher United States	16	1.0k 1.0×	709 1.1×	475 0.9×	799 2.2×	471 1.7×	23	1.6k
C H Nightingale United States	26	1.2k 1.2×	576 0.9×	962 1.8×	660 1.8×	261 1.0×	70	2.3k
Sandra L. Preston United States	25	1.1k 1.1×	676 1.0×	941 1.7×	519 1.4×	214 0.8×	45	2.4k
D. S. Reeves United Kingdom	26	699 0.7×	457 0.7×	668 1.2×	372 1.0×	231 0.9×	89	1.8k
H. Mattie Netherlands	24	1.2k 1.2×	596 0.9×	633 1.2×	460 1.3×	207 0.8×	108	2.2k
D. S. Reeves United Kingdom	25	680 0.7×	480 0.7×	438 0.8×	328 0.9×	211 0.8×	94	1.8k
Steven C. Ebert United States	16	1.7k 1.7×	1.1k 1.6×	854 1.6×	303 0.8×	362 1.3×	28	2.0k

Countries citing papers authored by J. Blaser

Since Specialization

Citations

This map shows the geographic impact of J. Blaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Blaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Blaser more than expected).

Fields of papers citing papers by J. Blaser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Blaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Blaser. The network helps show where J. Blaser may publish in the future.

Co-authorship network of co-authors of J. Blaser

This figure shows the co-authorship network connecting the top 25 collaborators of J. Blaser. A scholar is included among the top collaborators of J. Blaser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Blaser. J. Blaser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bize, Raphaël, et al.. (2022). Detecting and describing heterogeneity in health care cost trajectories among asylum seekers. BMC Health Services Research. 22(1). 978–978. 2 indexed citations

Grazioli, Véronique S., et al.. (2022). Risk Perception Related to COVID-19 and Future Affective Responses Among Healthcare Workers in Switzerland: A Mixed-Methods Longitudinal Study. International Journal of Public Health. 67. 1604517–1604517. 1 indexed citations

Blaser, J., Albina Nowak, Marcus Cheetham, et al.. (2021). Comorbidities Associated with Worse Outcomes Among Inpatients Admitted for Acute Gastrointestinal Bleeding. Digestive Diseases and Sciences. 67(8). 3938–3947. 10 indexed citations

Blaser, J., et al.. (2019). Protocol of a longitudinal study on the specific needs of Syrian refugee families in Switzerland. BMC International Health and Human Rights. 19(1). 32–32. 7 indexed citations

N’Goran, Alexandra, J. Blaser, Anouk Déruaz‐Luyet, et al.. (2016). From chronic conditions to relevance in multimorbidity: a four-step study in family medicine. Family Practice. 33(4). 439–444. 28 indexed citations

Blaser, J. & Jacques Cornuz. (2015). Experts’ consensus on use of electronic cigarettes: a Delphi survey from Switzerland. BMJ Open. 5(4). e007197–e007197. 12 indexed citations

Lovis, Christian & J. Blaser. (2015). Biomedical informatics in Switzerland: need for action. Swiss Medical Weekly. 145(2728). w14173–w14173. 1 indexed citations

Karlen, S., et al.. (2015). Too frequent low-dose methotrexate prescriptions: multicentre quality control and quality assurance with pre- and post-analysis. Swiss Medical Weekly. 145(4748). w14218–w14218. 1 indexed citations

Simon, Olivier, et al.. (2014). Réduction des risques et jeux d’argent. Questions ouvertes par la révision du dispositif suisse. SERVAL (Université de Lausanne). 12(2). 66–89. 5 indexed citations

10.

Beeler, Patrick E., et al.. (2014). Impact of electronic reminders on venous thromboprophylaxis after admissions and transfers. Journal of the American Medical Informatics Association. 21(e2). e297–e303. 15 indexed citations

11.

Kucher, Nils, et al.. (2009). Physician compliance with advanced electronic alerts for preventing venous thromboembolism among hospitalized medical patients. Journal of Thrombosis and Haemostasis. 7(8). 1291–1296. 40 indexed citations

12.

Blaser, J., et al.. (1995). Multicenter Quality Control Study of Amikacin Assay for Monitoring Once-Daily Dosing Regimens. Therapeutic Drug Monitoring. 17(2). 133–136. 11 indexed citations

13.

Blaser, J., et al.. (1995). Nephrotoxicity, high frequency ototoxicity, efficacy and serum kinetics of once versus thrice daily dosing of netilmicin in patients with serious infections. Journal of Antimicrobial Chemotherapy. 36(5). 803–814. 12 indexed citations

14.

Flückiger, Ursula, P Francioli, J. Blaser, M. P. Glauser, & Philippe Moreillon. (1994). Role of Amoxicillin Serum Levels for Successful Prophylaxis of Experimental Endocarditis Due to Tolerant Streptococci. The Journal of Infectious Diseases. 169(6). 1397–1400. 35 indexed citations

15.

Blaser, J., Béda Joos, Milos Opravil, & R Lüthy. (1993). Variability of serum concentrations of trimethoprim and sulfamethoxazole during high dose therapy. Infection. 21(4). 206–209. 19 indexed citations

16.

König, Christiane, Hans‐Peter Simmen, & J. Blaser. (1993). Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro. European Journal of Clinical Microbiology & Infectious Diseases. 12(7). 519–526. 26 indexed citations

17.

Blaser, J., et al.. (1992). Amikacin, Ceftazidime, and Flucloxacillin against Suspended and Adherent Pseudomonas aeruginosa and Staphylococcus epidermidis in an In Vitro Model of Infection. The Journal of Infectious Diseases. 165(2). 281–289. 29 indexed citations

18.

Dudley, Michael N., J. Blaser, Deborah Gilbert, Kenneth H. Mayer, & Stephen H. Zinner. (1991). Combination Therapy with Ciprofloxacin plus Azlocillin against Pseudomonas aeruginosa: Effect of Simultaneous versus Staggered Administration in an In Vitro Model of Infection. The Journal of Infectious Diseases. 164(3). 499–506. 32 indexed citations

19.

Schlaeffer, F., et al.. (1990). Enhancement of leucocyte killing of resistant bacteria selected during exposure to aminoglycosides or quinolones. Journal of Antimicrobial Chemotherapy. 25(6). 941–948. 11 indexed citations

20.

Blaser, J., et al.. (1983). Side-effects due to the intravenous infusion of erythromycin lactobionate. Infection. 11(3). 161–163. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact